Ceramide enhances COX-2 expression and VSMC contractile hyperreactivity via ER stress signal activation
Ceramide enhances COX-2 expression and VSMC contractile hyperreactivity via ER stress signal activation
复制标题
神经酰胺通过 ER 应激信号激活增强 COX-2 表达和 VSMC 收缩高反应性
DOI:
10.1016/j.vph.2017.08.001
复制
发表时间:
2017-09-01
影响因子:
4
通讯作者:
Qian, Zongjie
中科院分区:
文献类型:
--
作者:
Zhang, Huina;Li, Juanfen;Qian, Zongjie
Ceramide accumulation in blood vessels has been attributed to vascular dysfunction in progressive vascular complications in metabolic diseases. The present study showed that ceramide pretreatment promoted PE-induced vasoconstriction in rat endothelium-denuded vascular rings in a time- and dose-dependent manner. Endoplasmic reticulum (ER) stress inhibitors, 4-PBA and TUDCA, COX-2 inhibitors, Celecoxib and NS398, as well as PGE(2) receptor antagonist AH-6809 attenuated ceramide-promoted vascular hyperreactivity. Ceramide promoted the transcriptional and translational expression of COX-2 and BiP in VSMCs, which were blocked by the ER stress inhibitors, 4-PBA and TUDCA. These findings show that ceramide enhances PE-induced vascular smooth muscle constriction by mediation of the ER stress/COX-2/PGE(2) pathway. Therapeutic strategies targeted to reducing ER stress and COX-2 activation might be beneficial in attenuating vascular complications. Chemical compounds: C-2-Ceramide (N-acetyl-n-erythro-sphingosine) CID:2662Tauroursodeoxycholic Acid Sodium (TUDCA) CID:9848818phenylephrine (PE) CID:6041.